Price: $ 1295
BMI View: Several events in recent months illustrate growing interest in the potential of Zambia's healthcare and pharmaceuticals market. Barclays and GlaxoSmithKline announced that they will invest in the development of improved medicine supply chains, a pilot health insurance project and the creation of small health outlets; Novartis is collaborating in a campaign to reduce the impact of malaria in the country; and the government has also revealed progress made in the creation of a social health insurance plan for people in formal employment. These are all positive first steps, as are other moves such as plans to construct around 650 health outposts across the country. Zambia's healthcare market continues to create concerns, however. A lack of domestic manufacturing facilities means that the gov ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/295139.html
No comments:
Post a Comment